| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |